Displaying 1–15 of 15 results for PriceWaterhouse Coopers

Sort By Relevance Sort By Date

Taming the Supply Chain Monster

(Article)

FDASIA Title VII: Rx for Global Supply Chain Ills?

Digital Insights: Social Media Dislikes Pharma?

(Article)

How do we measure the impact of social media? It’s a question being addressed by most drug companies, who have their own theories and formulas.

Pharma 2020: Supplying the Future

(Whitepaper)

The pharma supply chain needs a radical overhaul, and PWC predicts that it will undergo three key changes over the next decade. It will fragment, with different models for different product types and patient segments. It will become a means of market differentiation and source of economic value. ...

Gatorade and Ketchup Do Not a Meal Make

(Article)

I am a sucker for pyramids of ketchup bottles and interesting displays of fruit drinks. If it jumps out at me, it usually comes home with me, and by that point I have forgotten why I even made the trip at all. The same holds true when I surf the web. I tend to get distracted by the initial ...

Pharma 2020: Virtual R&D

(Whitepaper)

The second paper in the PwC Pharma 2020 series, explores how pharma companies could dramatically improve the R&D productivity. It contends that by 2020 the R&D process may be shortened by two-thirds, success rates may dramatically increase, and clinical trial costs could be cut substantially. New...

Top Eight Health Industry Issues in 2008

(Whitepaper)

To help health executives and policy makers anticipate and prepare for what's ahead, PricewaterhouseCoopers’ Health Research Institute has identified the Top Eight Health Industry Issues in 2008. The report highlights impending changes — ranging from major changes in provider reimbursement, to ...

Pharma 2020: The Vision - Which Path Will You Take?

(Whitepaper)

This report, conducted by PriceWaterhouse Coopers indicates that the current pharmaceutical industry business model is both economically unsustainable and operationally incapable of acting quickly enough to produce the types of innovative treatments demanded by global markets. According to this ...

Tracking FDA’s Interaction with Industry

(Article)

The latest results in an ongoing survey suggest a communications gap and the need for industry to ask more questions, sooner, of FDA. They also indicate a need for better funding and staff retention within FDA.

Unlocking the Power of Pharmacovigilance

(Whitepaper)

The idea that controlled clinical trials can establish product safety and effectiveness is a core principle of the pharmaceutical industry. Neither the clinical trials process nor the approval procedures of the FDA, however, can provide a perfect guarantee of safety for all potential consumers ...

Gearing Up For a Global Gravity Shift

(Whitepaper)

The center of gravity of the global pharmaceutical industry is shifting with Asia set to the be the largest pharmaceutical market in the world. As a result, many multinational pharmaceutical companies are building up their presence in the region. This report provides insight into how companies ...

Improving America's Health IV : A Survey of the Working Relationship Between ...

(Whitepaper)

Despite the progress made during the past six years between the life sciences industry and the FDA, substantial issues remain and further improvements are needed. This survey examines these issues and offers perspectives on improvements that can be made to the regulatory review process and the ...

The New and Expanding Role of the CCO

(Article)

As pharmaceutical companies increasingly focus on regulatory concerns, a new executive role has emerged almost overnight. The latest star in the C-level pantheon at most drug makers is the chief compliance officer (CCO). What once was viewed as a part-time task, merely part of a chief legal ...

Productivity and the Economics of Regulatory Compliance

(Whitepaper)

This presentation developed by PriceWaterhouseCoopers Consulting examines the connection between compliance and cost savings.

Sort By Relevance Sort By Date